Greece: temporary ban on parallel exports PharmaTimes Regular price reductions have boosted parallel trade in innovative medicines out of Greece, resulting in shortages for patients in the country. 30 of the 34 drugs to come under the temporary ban are produced by multinationals, including one each from ... |